This cohort study evaluates the risk of self-harm and overdose among adolescents and young adults during vs before the COVID-19 pandemic.

No abstract

No abstract

No abstract

No abstract

Maternal death, although rare, is an often preventable event with devastating consequences for families and care providers. The World Health Organization estimates that more than 300 000 women die each year from pregnancy-or childbirth-related complications. 1 The World Health Organization and the Public Health Agency of Canada reported a rise in maternal mortality in Canada between 1990 and 2015, from 5.1 to 11.9 per 100 000 live births. 2,3 These findings prompted the Society of Obstetricians and Gynaecologists of Canada to work with federal and provincial partners to review maternal mortality surveillance. 4 The investigating committee found that national maternal health surveillance faced serious barriers relating to data access, coverage, timeliness and completeness. Moreover, they concluded that there was little standardization across jurisdictions with respect to definitions, data collection and maternal mortality review processes. 4,5 Although several provinces and

Amniotic fluid embolism (AFE) is a catastrophic, sudden-onset event that must be recognized immediately. Despite the rarity of this condition, both maternal and perinatal morbidity and mortality are significant with AFE, even in cases ideally managed. In this article, we present five key statements covering the risk factors, clinical presentation, and management of AFE in a clinical setting. The purpose of these tips is to provide clinicians with information that may improve their ability to make a timely diagnosis and establish appropriate supportive treatment to patients suffering from AFE. RésuméL’embolie amniotique est un événement catastrophique d’apparition soudaine qui doit être détecté immédiatement. Malgré la rareté de cette affection, la morbidité et la mortalité maternelles et périnatales sont importantes, même dans les cas où le traitement est idéal. Dans cet article, nous présentons cinq énoncés clés qui portent sur les facteurs de risque, le tableau clinique et la prise en charge de l’embolie amniotique dans un contexte clinique. Ces astuces visent à fournir aux cliniciens de l’information qui pourrait améliorer leur capacité à poser un diagnostic en temps opportun et à assurer un traitement de soutien approprié aux patientes atteintes d’une embolie amniotique.

Maternal mortality is the death of a woman while pregnant or within 42 days of the end of pregnancy. Late maternal deaths are from 42 to 365 days thereafter. Maternal mortality is an important surrogate indicator of a woman's overall health, social and economic status, and the provision of antenatal and emergency obstetric care at regional and national levels. Canada does not have a national system to report on maternal mortality; rather, maternal death investigations fall under the legal purview of coroners and medical examiners within each individual province or territory. Furthermore, the Canadian Perinatal Surveillance System is limited by its access to a comprehensive dataset. Hence, there is no accurate national picture of mortality prevalence or trends. The implementation of a national confidential enquiry system is a crucial step toward detailing pregnancy and post-pregnancy maternal mortality in Canada and should be organized in accordance with existing successful international systems.